Highlighting the urgency, the advisory
stresses the imperative need for preventive measures and swift treatment to
contain the spread of Whooping Cough. Authorities express concerns about a
potential surge in cases in the upcoming months, which could strain hospital
resources.
Whooping Cough, known for its high
contagion through coughing and sneezing, has led the health institute to urge
individuals to take necessary precautions to prevent bacterial transmission
causing the illness.
In a related development, a
pharmaceutical company in Peshawar faces scrutiny after the discovery of toxic
substances in its cough syrup. The Drug Regulatory Authority has recalled the
affected cough syrup, exposing the presence of hazardous propylene glycol
imported from Thailand. Ongoing investigations aim to take appropriate actions
against those responsible.
Simultaneously, another alarming
revelation surfaces as the World Health Organization issues an alert regarding
a Lahore-based pharmaceutical company producing contaminated cough syrup. The
company's product was found to contain harmful impurities, leading the company
to halt syrup production last month.
As the situation unfolds, global health
organizations closely monitor the pertussis outbreak in Pakistan. The World
Health Organization flags another pharmaceutical company in Lahore for
manufacturing cough syrup with toxic contaminants.
The pertussis outbreak in Pakistan raises
serious concerns about public health and the quality control of pharmaceutical
products. Swift actions are imperative to prevent further spread, and
regulatory authorities must ensure the safety and integrity of medical supplies
in the country.
0 Comments